Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03428-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Yang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Medical and Health Science-Technology Innovation Project of the Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. gaoshugeng@cicam…
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Medical and Health Science-Technology Innovation Project of the Chinese Academy of Medical Sciences
- Central Health Research Key Projects
- Research Project of the Institute
Zitieren
APA
Liu, Y., Bie, F., Bai, G., Huai, Q., Li, Y., Chen, X., Zhou, B., & Gao, S. (2024). Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03428-1
Vancouver
Liu Y, Bie F, Bai G, Huai Q, Li Y, Chen X, et al. Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03428-1
BibTeX
@article{Liu2024,
author = {Liu, Yang and Bie, Fenglong and Bai, Guangyu and Huai, Qilin and Li, Yuan and Chen, Xiaowei and Zhou, Bolun and Gao, Shugeng},
title = {Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03428-1}
}
EUVIMED